INST NATL DE LA SANTE & DE LA RECH MEDICAL has a total of 47 patent applications. It decreased the IP activity by 30.0%. Its first patent ever was published in 2015. It filed its patents most often in Japan. Its main competitors in its focus markets pharmaceuticals, biotechnology and measurement are PETER MACCALLUM CANCER INST, AEGERA THERAPEUTICS INC and UNIV SAINT LOUIS.
# | Country | Total Patents | |
---|---|---|---|
#1 | Japan | 47 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Measurement | |
#4 | Medical technology | |
#5 | Macromolecular chemistry and polymers | |
#6 | Environmental technology | |
#7 | Machines |
# | Name | Total Patents |
---|---|---|
#1 | Bernhald Mlecnik | 5 |
#2 | Didier Letourneur | 5 |
#3 | Jerome Galon | 5 |
#4 | Franck Pages | 5 |
#5 | Sidi Mohammed Derkaoui | 4 |
#6 | Catherine Le Visage | 4 |
#7 | Samir Hamamah | 4 |
#8 | Sylvain Catros | 3 |
#9 | Frederic Jaisser | 3 |
#10 | Jean-Christophe Fricain | 3 |
Publication | Filing date | Title |
---|---|---|
JP2020203921A | MIF inhibitors for the acute or chronic treatment of pulmonary hypertension | |
JP2019038842A | Methods and pharmaceutical compositions for treatment of pancreatic cancers | |
JP2018183166A | Anti-human her3 antibody which is non-competitive and allosteric with respect to neuregulin and use thereof | |
JP2017122098A | Fucoidans as ligands for diagnosis of degenerative pathologies |